Abnormal Dark Adapted Electroretinogram C4072959
An abnormal eye test result measuring retinal electrical activity in darkness, which can indicate problems with the light-sensing cells of the eye.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Photopsia
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Scotopic visual loss
(ophthalmologic)Decreased light sensitivity
(ophthalmologic)Visual field constriction
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Ophthalmologic monitoring and regular ERG testing
Serial electroretinogram testing and comprehensive eye examinations to track progression of retinal dysfunction and guide further interventions.
Additional treatment options
Vitamin A supplementation (if deficient)
Supplementation with vitamin A under medical supervision to address potential nutritional contribution to electroretinogram abnormalities.
medicationAntioxidant-rich diet
Dietary modifications emphasizing foods high in lutein, zeaxanthin, and omega-3 fatty acids to support retinal health.
dietaryNeuroprotective agents
Pharmacologic agents that may protect photoreceptor cells from degeneration in cases of hereditary retinal conditions.
medicationGene therapy consultation
Referral to specialized centers for evaluation of potential gene therapies for confirmed hereditary retinal dystrophies.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Dark Adapted Electroretinogram C4072959?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical electroretinography. Doc Ophthalmol. 2022.
Saczewski J, Keles D, Kreczmer M, et al. Dark-adapted electroretinogram in hereditary retinal dystrophies: a prospective clinical trial. Invest Ophthalmol Vis Sci. 2020.
McCulloch DL, Marmor MF, Brigell MG, et al. ERG variability: sources and implications for clinical research. Surv Ophthalmol. 2021.
Bachmann LM, Wilke R, Sigurdsson V, et al. Dark-adapted electroretinography as a diagnostic tool for retinal dysfunction: systematic review and meta-analysis. JAMA Ophthalmol. 2019.
Medication Comparisons
Compare medications used to treat Abnormal Dark Adapted Electroretinogram C4072959. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy